Literature DB >> 15622358

Midterm pivotal trial results of the Talent Low Profile System for repair of abdominal aortic aneurysm: analysis of complicated versus uncomplicated aortic necks.

Ronald M Fairman1, Omaida C Velazquez, Jeffrey P Carpenter, Edward Woo, Richard A Baum, Michael A Golden, Boonprasit Kritpracha, Frank Criado.   

Abstract

OBJECTIVE: This study was undertaken to determine whether a complicated aortic neck is associated with unfavorable outcome after abdominal aortic aneurysm (AAA) endografting.
METHODS: In a prospective pivotal clinical trial, 237 consecutive patients underwent implantation of the bifurcated Talent Low Profile System. Patients were divided into 2 groups, those with complicated aortic necks (short, <15 mm; very short, < or =10 mm; dilated, >28 mm; angulated, >45 degrees; calcified; and thrombus-lined) versus those with uncomplicated neck anatomy. Major outcome parameters included procedure time, operative blood loss, transfusion requirements, volume of contrast medium used during the implant procedure, endoleaks, migration, limb patency, AAA regression, conversion to open repair, morbidity, and mortality. Mean follow-up was 620.5 days.
RESULTS: Overall, 32% of aortic necks were short, 19% were very short, 20% were dilated, 18% were calcified, 8.5% were thrombus-lined, and 19.9% were angulated. Thirty percent and 70% of patients, respectively, were stratified to the uncomplicated and complicated groups ( P < .01. Procedure time, operative blood loss, transfusions, volume of contrast medium used in the implant procedure, migration, endograft patency, AAA sac regression, conversion to open repair, and mortality were not significantly different in necks with complicated versus uncomplicated anatomy. At 21 months, sacs were regressing or stable in 98% (complicated) versus 96% (uncomplicated). Primary graft limb patency was 100% in both groups. The endoleak rate was 4.3% (complicated) versus 17% (uncomplicated) at 18 months, but this difference was not statistically significant. Adverse renal events, however, occurred in 27.5% (complicated) versus 13.6% (uncomplicated; P = .04).
CONCLUSIONS: Complicated aortic neck is not associated with unfavorable outcome at midterm follow-up after AAA endografting. However, statistically more adverse renal events occur in patients with complicated neck anatomy.

Entities:  

Mesh:

Year:  2004        PMID: 15622358     DOI: 10.1016/j.jvs.2004.09.013

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Editor's Choice - Renal complications after EVAR with suprarenal versus infrarenal fixation among all users and routine users.

Authors:  S L Zettervall; S E Deery; P A Soden; K Shean; J J Siracuse; M Alef; V I Patel; M L Schermerhorn
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-08-02       Impact factor: 7.069

2.  Engineering silicone rubbers for in vitro studies: creating AAA models and ILT analogues with physiological properties.

Authors:  T J Corbett; B J Doyle; A Callanan; M T Walsh; T M McGloughlin
Journal:  J Biomech Eng       Date:  2010-01       Impact factor: 2.097

3.  Comparison of Renal Complications between Endografts with Suprarenal and Infrarenal Fixation.

Authors:  S L Zettervall; P A Soden; S E Deery; K Ultee; K E Shean; F Shuja; R L Amdur; M L Schermerhorn
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-03-06       Impact factor: 7.069

Review 4.  Is Evar Feasible in Challenging Aortic Neck Anatomies? A Technical Review and Ethical Discussion.

Authors:  Pasqualino Sirignano; Silvia Ceruti; Francesco Aloisi; Ascanio Sirignano; Mario Picozzi; Maurizio Taurino
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

Review 5.  Renal outcomes of suprarenal vs. infrarenal endograft fixation in endovascular abdominal aortic aneurysm repair: a narrative review.

Authors:  Alexander Geragotellis; Kofi Cox; Ho Cheung Anthony Yip; Matti Jubouri; Ian M Williams; Damian M Bailey; Mohamad Bashir
Journal:  Cardiovasc Diagn Ther       Date:  2022-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.